Kashiv Pharma LLC, a pharmaceutical research and drug delivery company, announced it has acquired the assets of Adello Biologics LLC, a biotechnology company based in Piscataway.
Under the deal, Kashiv will be renamed to Kashiv BioSciences LLC and its company headquarters will be based in Bridgewater. It currently has research and development and manufacturing facilities in Bridgewater, Piscataway, Chicago and Ahmedabad, India.
“The acquisition of Adello will create a fully integrated biosciences company with a strong platform for growth,” said Chintu Patel, who will become CEO of Kashiv BioSciences. “The combined breadth of expertise in small and large molecules, peptides, proteins and monoclonal antibodies will enable us to develop products with meaningful clinical differentiation and a compelling value proposition for patients, physicians and payers.”
